NCT01656993View on ClinicalTrials.gov

Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Congenital Heart Disease
Trial Locations (1)

84113

Primary Children's Medical Center, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT01656993 - Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts | Biotech Hunter | Biotech Hunter